Varicose Vein Treatment Devices Market, By Device Type (Ablation Devices, Venous Closure Products, Others), By Treatment Type (Sclerotherapy, Endovenous Ablation, Surgical Ligation & Stripping, Others), By End User (Specialty Clinics, Hospitals, Ambulatory Surgical Centers, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Mar 2024

Code : CMI246

Pages :174

Formats :

Excel and PDF

Industry : Medical Devices

Key Developments

On January 29, 2024, VVT Medical, a company specializing in medical devices, unveiled a significant strategic distribution partnership with Methapharm, a specialized pharmaceutical firm. This collaboration marks a significant advancement in the realm of varicose vein treatment, as it leverages the combined expertise of both entities to market VVT Medical's ScleroSafe platform across the U.S.
In April 2022, I-VASC Srl, a medical device company, disclosed the finalization of a USD 1.96 million Series A investment aimed at promoting its product, VELEX, a device designed for the treatment of chronic venous insufficiency. The funds from this investment round are earmarked for conducting post-market clinical research, securing U.S. FDA approval for entry into the U.S. market, and finalizing the industrialization process of the product.
In December 2021, BD, a renowned leader in medical technology worldwide, revealed its acquisition of Venclose, Inc., a company specializing in developing solutions for addressing chronic venous insufficiency (CVI), a condition resulting from faulty valves that can lead to varicose veins. This strategic move empowers BD to offer an enhanced portfolio of solutions to healthcare providers who manage various venous diseases, further solidifying its position in the market.
In October 2020, InVera Medical, an inventive medical device company headquartered in Galway, Ireland, recently secured USD 5.3 million in seed equity capital to accelerate the advancement of its groundbreaking InVera device for chronic venous disease. Representing a significant milestone, InVera stands as the world's inaugural medical device harnessing the body's biological response to address varicose veins and venous ulcers, devoid of any detrimental side effects.

*Definition:The varicose vein treatment devices market consists of medical equipment and supplies used to treat varicose veins without surgery. Some common treatment devices in this market include laser and light therapy devices, venous closure systems, and radiofrequency endovenous systems. These non-invasive varicose vein treatment devices use techniques like laser energy, radio waves, or closure mechanisms to eliminate varicose veins and reduce symptoms like pain, leg fatigue, and appearance of bulging veins near the surface of the skin.